$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pharmaceutical multiple unit particulate formulation in the form of coated cores 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/16
  • A61K-047/02
출원번호 US-0509107 (1995-08-01)
우선권정보 DK-0000695 (1994-06-15)
발명자 / 주소
  • Norling Tomas,DKX
  • Jensen Lone Norgaard,DKX
  • Hansen Jens,DKX
출원인 / 주소
  • Dumex-Alpharma A/S, DKX
대리인 / 주소
    Watov & Kipnes, P.C.
인용정보 피인용 횟수 : 122  인용 특허 : 9

초록

A pharmaceutical multiple unit particulate formulation in the form of coated cores which includes a pharmaceutically acceptable carrier selected from calcium carbonate, calcium silicate, calcium magnesium silicate, calcium phosphate, kaolin, sodium hydrogen carbonate, sodium sulfate, barium carbonat

대표청구항

[ We claim:] [1.] A pharmaceutical multiple unit particulate formulation comprising individual units in the form of coated cores, wherein at least 50% w/w of the cores before coating have a particle size within a range of about 90-225 .mu.m, when tested as described herein, each coated core comprisi

이 특허에 인용된 특허 (9)

  1. Abramowitz Robert (Somerset NJ) Joshi Yatinda M. (Piscataway NJ) Jain Nemichand B. (Monmouth Junction NJ), Captopril formulation providing increased duration of activity.
  2. Arnold Raymond E. (San Francisco CA) Becker Nathaniel T. (Burlingame CA) Boston Matthew G. (San Carlos CA) Mansikkamaki Aino (Hanko CA FIX) Simpson Curran M. (Montara CA) Wendt Daniel J. (Belmont CA), Enzyme-containing granules coated with hydrolyzed polyvinyl alcohol or copolymer thereof.
  3. Ando Shinji (Nagoya JPX) Ohtaguro Masami (Nagoya JPX) Masuda Takayoshi (Tohkai JPX) Watanabe Yoshimoto (Kasugai JPX), Granule containing physiologically-active substance, method for preparing same and use thereof.
  4. Volkonsky Viktor A. (Moscow RUX) Dvukhsherstnov Sergei D. (Moscow RUX) Chernyakov Sergei V. (Moscow RUX), Magnetically responsive composition for carrying biologically active substances and methods of production.
  5. Hhl Rolf (Hofheim am Taunus DEX) Heine Helmut (Kronberg DEX), Method for isolating solid matter from a salinomycin culture broth.
  6. Gordon Harry W. (Bronx NY) Schaffner Carl P. (Trenton NJ), Polyenic macrolide compositions.
  7. Iwasaki Tetsuji (Wakayama JPX) Goto Takuo (Wakayama JPX) Matsumoto Tadao (Osaka JPX), Process for the preparation of granular pesticide.
  8. Tsuru Sumiaki (Tokyo JPX) Tsugita Masashi (Tokorozawa JPX) Takasaki Ken (Tokyo JPX) Yokoo Akihiko (Tokyo JPX) Ichitsuka Takeshi (Tokyo JPX), Slow release drug delivery granules and process for production thereof.
  9. Oystese ; Brigt, Zinc bacitracin composition for use as a feed supplement and method for making the same.

이 특허를 인용한 특허 (122)

  1. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  2. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  3. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  4. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  5. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  6. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  7. Sun Ying ; Liu Jue-Chen ; Kimbleton Elizabeth ; Wang Jonas C. T., Acidified composition for topical treatment of nail and skin conditions.
  8. Labruzzo, Carla, Beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and process for obtaining them.
  9. Bologna, William J.; Levine, Howard L.; DeZiegler, Dominque, Bioadhesive progressive hydration tablets.
  10. Levine, Howard L.; Bologna, William J.; De Ziegler, Dominique, Bioadhesive progressive hydration tablets.
  11. Levine,Howard L.; Bologna,William J.; Cartier,Philippe J.; De Ziegler,Dominique, Bioadhesive progressive hydration tablets.
  12. Bologna William J.,FRX ; Levine Howard L. ; Cartier Philippe,FRX ; de Ziegler Dominique,FRX, Bioadhesive progressive hydration tablets and methods of making and using the same.
  13. Baichwal, Anand R.; Woodcook, Paul; Higgins, Raymond; Cobb, Jaclyn, Chronotherapeutic dosage forms and methods of treatment using chronotherapy.
  14. Mehta, Ketan; Tu, Yu-Hsing, Clonidine formulation.
  15. Schwarzentruber, Patrick; Di Maiuta, Nicola; Schoelkopf, Joachim; Ridgway, Catherine Jean; Gane, Patrick A. C., Coated controlled release active agent carriers.
  16. Avalle, Nadia, Coated cosmetic powder.
  17. Sharma, Vinay K.; Hussain, Javed; Khorakiwala, Habil F., Composition for pulsatile delivery of diltiazem and process of manufacture.
  18. Oki, Toshikazu; Hanafusa, Takashi; Haruta, Shunji, Compositions for nasal administration of pharmaceuticals.
  19. Bettini, Ruggero; Arduini, Lauro; Bertolini, Francesca; Camellini, Claudia, Compositions of microparticles and granules for oral controlled release of substances for veterinary use.
  20. Nagata, Ryoichi; Haruta, Shunji, Compositions that enable rapid-acting and highly absorptive intranasal administration.
  21. Oki, Toshikazu; Hanafusa, Takashi; Haruta, Shunji, Compositons for nasal administration of pharmaceuticals.
  22. Morioka, Shigeru; Iwasaki, Yoshiya; Seo, Yasufumi, Compression molded product of effervescent chlorinated isocyanuric acid.
  23. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Wood, Jr., Lowell L., Computational and/or control systems and methods related to nutraceutical agent selection and dosing.
  24. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Tegreene, Clarence T.; Wood, Jr., Lowell L., Computational systems and methods related to nutraceuticals.
  25. Heinicke Grant W.,AUX ; Lepore Angelo,AUX ; Morella Angelo M.,AUX, Controlled absorption diltiazem pharmaceutical formulation.
  26. Heinicke Grant W.,AUX ; Lepore Angelo,AUX ; Morella Angelo M.,AUX, Controlled absorption diltiazem pharmaceutical formulation.
  27. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  28. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  29. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  30. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  31. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  32. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  33. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  34. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  35. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  36. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  37. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  38. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  39. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  40. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
  41. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  42. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  43. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  44. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  45. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  46. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  47. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  48. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  49. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  50. Baichwal, Anand R.; Woodcock, Paul; Higgins, Raymond; Cobb, Jaclyn, Delayed release dosage forms.
  51. Domb,Abraham J., Dispersible concentrate for the delivery of cyclosprin.
  52. Lynenskhold,Eva; J��rgensen,Lone N��rgaard, Drug carrier pellet production process.
  53. Chang, Rong-Kun; Couch, Richard A.; Burnside, Beth A., Drug formulations having reduced abuse potential.
  54. Chang, Rong-Kun; Couch, Richard A.; Burnside, Beth A., Drug formulations having reduced abuse potential.
  55. Dennett, Jr., Edmund V.; Wells, David S., Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof.
  56. Pather, S. Indiran; Robinson, Joseph R.; Eichman, Jonathan D.; Khankari, Rajendra K.; Hontz, John; Gupte, Sangeeta V., Effervescent drug delivery system for oral administration.
  57. Pather, S. Indiran; Robinson, Joseph R.; Eichman, Jonathan D.; Khankari, Rajendra K.; Hontz, John; Gupte, Sangeeta V., Effervescent drug delivery system for oral administration.
  58. Pather, S. Indiran; Robinson, Joseph R.; Eichman, Jonathan D.; Khankari, Rajendra K.; Hontz, John; Gupte, Sangeeta V., Effervescent drug delivery system for oral administration.
  59. S. Indiran Pather ; Joseph R. Robinson ; Jonathan D. Eichman ; Rajendra K. Khankari ; John Hontz ; Sangeeta V. Gupte, Effervescent drug delivery system for oral administration.
  60. Moe, Derek; Agarwal, Vikas; Habib, Walib, Effervescent oral fentanyl dosage form and methods of administering fentanyl.
  61. Moe, Derek; Agarwal, Vikas; Habib, Walid, Effervescent oral fentanyl dosage form and methods of administering fentanyl.
  62. Moe, Derek, Effervescent oral opiate dosage forms and methods of administering opiates.
  63. Moe, Derek, Effervescent oral opiate dosage forms and methods of administering opiates.
  64. Edgren, David E.; Wong, Patrick S.-L.; Bhatti, Gurdish K.; Li, Shu; Skluzacek, Robert R., Extended release dosage form.
  65. Gower, Brad L.; Castaneda, Carlos H.; Park, Jae Han; Herman, Clifford J., Extended release, abuse deterrent pharmaceutical compositions.
  66. Opitz Michaela,DEX ; Von Buren Hendrik,DEX ; Gabel Rolf-Dieter,DEX ; Lee Geoffrey,DEX, Fast decomposing pellets.
  67. Brzeczko, Albert W.; Doney, John A., Formulation process method to produce spray dried products.
  68. Carla Patricia Goncalves Mendes PT; Maria Julia Caeiro Ramalho de Oliveira PT, Gastroresistant multi-unitary pharmaceutical preparations containing piroxicam.
  69. Moe, Derek; Agarwal, Vikas; Habib, Walib, Generally linear effervescent oral fentanyl dosage form and methods of administering.
  70. Moe, Derek; Agarwal, Vikas; Habib, Walid, Generally linear effervescent oral fentanyl dosage form and methods of administering.
  71. Hudson, Bruce W.; Markland, Peter, Implant devices that differ by release profile and methods of making and using same.
  72. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Wood, Lowell L., Individualized pharmaceutical selection and packaging.
  73. Tsutsui, Tatsuo; Nagata, Ryoichi; Haruta, Shunji, Intranasal granisetron and nasal applicator.
  74. Nagata, Ryoichi; Haruta, Shunji, Intranasal pharmaceutical compositions with improved pharmacokinetics.
  75. Chang, Rong-Kun, Less abusable pharmaceutical preparations.
  76. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  77. Salaspuro, Mikko; Marvola, Martti, Method and preparation for binding acetaldehyde in saliva, stomach and large intestine.
  78. Beyerinck, Ronald A.; Ray, Roderick J.; Dobry, Dan E.; Settell, Dana M., Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles.
  79. Beyerinck, Ronald A.; Deibele, Heather L. M.; Dobry, Dan E.; Ray, Roderick J.; Settell, Dana M.; Spence, Ken R., Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus.
  80. Beyerinck, Ronald A.; Deibele, Heather L. M.; Dobry, Dan E.; Ray, Roderick J.; Settell, Dana M.; Spence, Ken R., Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus.
  81. Beyerinck, Ronald A.; Diebele, Heather L. M.; Dobry, Dan E.; Ray, Roderick J.; Settell, Dana M.; Spence, Ken R., Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus.
  82. Wagner, Torsten, Method for producing encased spherical granular grains.
  83. Rubino, Orapin P.; Jones, David M.; Bretschneider, Frank; Fankhauser, Peter; Prasch, Armin, Method of preparing biologically active formulations.
  84. Rubino, Orapin P.; Jones, David M.; Bretschneider, Frank; Frankhauser, Peter; Prasch, Armin, Method of preparing biologically active formulations.
  85. Fujii, Seishiro; Dotto, Gian Paolo, Methods and compositions for reducing skin damage.
  86. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Tegreene, Clarence T.; Wood, Jr., Lowell L., Methods and systems related to receiving nutraceutical associated information.
  87. Jung, Edward K. Y.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Tegreene, Clarence T.; Wood, Jr., Lowell L., Methods and systems related to transmission of nutraceutical associated information.
  88. Staas, Jay K.; Tice, Thomas R.; Hudson, Bruce W.; Tipton, Arthur J., Methods for manufacturing delivery devices and devices thereof.
  89. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
  90. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
  91. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
  92. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
  93. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  94. Jeary,Theresa Ann; Morrissey,Catherine Ann; Stark,Paul, Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
  95. Devane, John G.; Stark, Paul; Fanning, Niall M. M., Multiparticulate modified release composition.
  96. Devane, John G.; Stark, Paul; Fanning, Niall M. M.; Rekhi, Gurvinder Singh, Multiparticulate modified release composition.
  97. Devane, John G; Stark, Paul; Fanning, Niall M. N.; Rekhi, Gurvinder Singh; Jenkins, Scott A.; Liversidge, Gary, Nanoparticulate and controlled release compositions comprising cefditoren.
  98. Kao, Haui-Hung; Baichwal, Anand R.; McCall, Troy; Lee, David, Oxymorphone controlled release formulations.
  99. Kao, Huai-Hung; Baichwal, Anand R.; McCall, Troy; Lee, David, Oxymorphone controlled release formulations.
  100. Kao, Huai-Hung; Baichwal, Anand R.; McCall, Troy; Lee, David, Oxymorphone controlled release formulations.
  101. Lizio, Rosario; Petereit, Hans-Ulrich; Roth, Erna; Damm, Michael; Alexowsky, Ruediger, Partly neutralised anionic (meth) acrylate copolymer.
  102. Chen, Jun, Paste formulations.
  103. Pather, S. Indiran; Robinson, Joseph R.; Eichman, Jonathan D.; Khankari, Rajendra K.; Hontz, John, Pharmaceutical compositions for rectal and vaginal administration.
  104. Garavani, Alberto; Marchiorri, Maurizio; Di Martino, Alessandro; Mateo Echanagorria, Angel, Pharmaceutical formulations for thyroid hormones.
  105. Ly, Tai Wei; Raaum, Erik Dean, Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors.
  106. Tsutsui, Tatsuo, Powder medicine applicator for nasal cavity.
  107. Nagata, Ryoichi; Haruta, Shunji, Preparation for transnasal application.
  108. Nagata, Ryoichi; Haruta, Shunji, Preparation for transnasal application.
  109. Domb, Abraham J.; Avramoff, Avi; Pevzner, Victor, Pro-nanodispersion for the delivery of cyclosporin.
  110. Biggs, Danielle; Nettles, Heather, Process for preparing microparticles having a low residual solvent volume.
  111. Michaela Opitz DE; Hendrik Von Buren DE; Rolf-Dieter Gabel DE; Geoffrey Lee DE, Rapidly disintegrating coated pellets with delayed release.
  112. Eichman, Jonathan D.; Hontz, John; Khankari, Rajendra K.; Pather, Sathasivan Indiran; Robinson, Joseph R., Sublingual buccal effervescent.
  113. Eichman, Jonathan D.; Hontz, John; Khankari, Rajendra K.; Pather, Sathasivan Indiran; Robinson, Joseph R., Sublingual buccal effervescent.
  114. Pather, S. Indiran; Khankari, Rajendra K.; Eichman, Jonathan D.; Robinson, Joseph R.; Hontz, John, Sublingual buccal effervescent.
  115. Pather, Sathasivan Indiran; Khankari, Rajendra K.; Eichman, Jonathan D.; Robinson, Joseph R.; Hontz, John, Sublingual buccal effervescent.
  116. Baichwal,Anand R.; Kao,Huai Hung; McCall,Troy W., Sustained release formulations of oxymorphone.
  117. Singh Shiva P.,INX ; Mukarram Siddiqui Mohammed Jaweed,INX ; Kulkami Dilip Ganesh,INX ; Purohit Manish,INX, Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole.
  118. Jung, Edward K. Y.; Leuthardt, Eric C.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Rinaldo, Jr., John D.; Wood, Jr., Lowell L., Systems and methods for transmitting pathogen related information and responding.
  119. Kenji Tominaga JP; Takaaki Hamada JP, Transdermal methotrexate preparations.
  120. Eichman, Jonathan D.; Hontz, John; Khankari, Rajendra K.; Pather, Sathasivan Indiran; Robinson, Joseph R., Transmucosal effervescent.
  121. Ryles, Christine Watson; Williams, David Robert; Ziemkiewicz, Alexander George; Urbaez, Jesus Antonio, Zinc citrate beads in oral compositions.
  122. Ryles, Christine Watson; Williams, David Robert; Ziemkiewicz, Alexander George; Urbaez, Jesus Antonio, Zinc citrate beads in oral compositions.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로